Therefore, in this study we hypothesized that PPAR-γ activation might inhibit ox-LDL-induced LOX-1 by targeting miR-590-5p, which improved and even reversed the pathological course of atherosclerosis. This evidence concerns the gene PPARG and atherosclerosis.